图书简介
Case Studies in Pharmacy Ethics explores the range of ethics situations faced by pharmacists in daily practice, from direct patient care to broad systemic issues. Using cases and commentaries, the book provides tools to assist pharmacists in understanding and resolving ethical issues.
Introduction: Four Questions of Ethics; What Are the Source, Meaning, and Justification of Ethical Claims?; 1. Distinguish Between Evaluative Statements and Statements Presenting Nonevaluative Facts; 2. Distinguish Between Moral and Nonmoral Evaluations; 3. Determine Who Ought to Decide; What Kinds of Acts Are Right?; Consequentialism; Deontological or Duty-Based Ethics; Other Issues of Normative Ethics; How Do Rules Apply to Specific Situations?; What Ought to Be Done in Specific Cases?; Notes; PART I: Ethics and Values in Pharmacy; Chapter 1: A Model for Ethical Problem Solving; The Five-Step Model; Application of the Model; 1. Respond to the Sense That Something Is Wrong; 2. Gather Information; 3. Identify the Ethical Problem/Moral Diagnosis; 4. Seek a Resolution; 5. Work with Others to Choose a Course of Action; Notes; Chapter 2: Values in Health and Illness; Identifying Value Judgments in Pharmacy; Separating Ethical and Other Evaluations; Chapter 3: What Is the Source of Moral Judgments?; Grounding Ethics in the Professional Code; Grounding Ethics in the Prescriber’s Orders; Grounding Ethics in Hospital Policy; Grounding Ethics in the Patient’s Values; Grounding Ethics in Religious or Philosophical Perspectives; Notes; PART II: Ethical Principles in Pharmacy Ethics; Chapter 4: Benefiting the Patient and Others: The Duty to Do Good and Avoid Harm; Benefiting the Patient; Health in Conflict with Other Goods; Relating Benefits and Harms; Benefits of Rules and Benefits in Specific Cases; Benefiting Society and Individuals Who Are Not Patients; Benefits to Society; Benefits to Specific Nonpatients; Benefit to the Profession; Benefit to the Pharmacist and the Pharmacist’s Family; Notes; Chapter 5: Justice: The Allocation of Health Resources; Justice Among Patients; Justice Between Patients and Others; Justice in Public Policy; Justice and Other Ethical Principles; Notes; Chapter 6: Autonomy; Determining Whether a Patient Is Autonomous; External Constraints on Autonomy; Overriding the Choices of Autonomous Persons; Notes; Chapter 7: Veracity: Dealing Honestly with Patients; The Condition of Doubt; Lying in Order to Benefit; Protecting the Patient by Lying; Protecting the Welfare of Others; Special Cases of Truth Telling; Patients Who Don’t Want to Be Told; Family Members Who Insist the Patient Not Be Told; The Right of Access to Medical Records; Notes; Chapter 8: Fidelity: Promise-Keeping and Confidentiality; The Ethics of Promises: Explicit and Implicit; The Limits on the Promise of Confidentiality; Breaking Confidence to Benefit the Patient; Breaking Confidence to Benefit Others; Incompetent, Impaired, and Dishonest Colleagues; Notes; Chapter 9: Avoidance of Killing; Active Killing Versus Letting One Die; Withholding Versus Withdrawing Treatment; Direct Versus Indirect Killing; Justifiable Omissions; Voluntary and Involuntary Killing; Killing as Punishment; Notes; Part III: Special Problem Areas; Chapter 10: Abortion, Sterilization, and Contraception; Abortion; Abortion for Medical Problems of the Fetus; Abortion Following Sexual Assault; Abortion to Save the Life of the Pregnant Woman; Abortion and the Mentally Incapacitated Woman; Abortion for Socioeconomic Reasons; Sterilization; Contraception; Notes; Chapter 11: Genetics, Birth, and the Biological Revolution; Genetic Counseling; Genetic and Genomic Screening; In Vitro Fertilization; Surrogate Motherhood; Gene Therapy; Notes; Chapter 12: Mental Health and Behavior Control; The Concept of Mental Health; Mental Illness and Autonomous Behavior; Mental Illness and Third-Party Interests; Other Behavior-Controlling Therapies; Notes; Chapter 13: Formularies and Drug Distribution Systems; Formularies; Eliminating Unproven Therapies; Eliminating Proven but Marginally Beneficial Therapies; Eliminating Proven but Cost-Ineffective Therapies; Appeals to Override Formularies; Physician Behavior with Drug Company Influence; Drug Distribution Systems; Mail-Order Pharmacies; Drugs from Outside the US; Notes; Chapter 14: Health Insurance, Health System Planning, and Rationing; Patient Autonomy and Mandated Insurance; Morally Controversial Treatment Coverage; Insurance Coverage for Expensive Drugs; Marginally Beneficial, Expensive Medications; Off-label Therapies; Notes; Chapter 15: Experimentation on Human Subjects; Calculating Risks and Benefits; Privacy and Confidentiality; Equity in Research; Conflicts of Interest in Research; Informed Consent in Research; Notes; Chapter 16: Consent and the Right to Refuse Treatment; The Elements of a Consent; The Standards for Consent; Comprehension and Voluntariness; Notes; Chapter 17: Death and Dying; The Definition of Death; Competent and Formerly Competent Patients; Never-Competent Patients; Limits Based on Interests of Others; Notes; Appendix: Codes of Ethics
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐